US 7122681
Desolvation process for the production of atorvastatin hemi-calcium essentially free of bound organic solvent
granted A61PA61P3/06A61P43/00
Quick answer
US patent 7122681 (Desolvation process for the production of atorvastatin hemi-calcium essentially free of bound organic solvent) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61P, A61P3/06, A61P43/00, A61P9/10